Research updates
Browse dated psilocybin research updates, separate publication dates from indexing dates, explore monthly literature and follow confirmed research alerts.
Free access · No subscription for research tools or data exports
Observed research changes
Changes are recorded when registry data are refreshed. The initial snapshot is a baseline, not historical news. A registry-added result reference may point to an older publication; its observation date is not the paper's publication date.
Recruitment status changed to recruiting · NCT07582120A Pilot Mechanistic Study of Psilocybin-Assisted Therapy as a Treatment for Depression · observed Nov 18, 2026 02:23 UTCRecruitment status changed to recruiting · NCT07719088An Examination of Psilocybin Effects on Biomarkers of Longevity, Healthy Aging, and Purpose in Life · observed Nov 18, 2026 02:23 UTCRegistry status changes · NCT06919640Psilocybin With Intracranial Neural Sensing · observed Nov 13, 2026 02:33 UTCRecruitment status changed to recruiting · NCT07296328Effects of Psilocybin on Speech Fluency, Struggle, and Brain Activity in People Who Stutter · observed Nov 11, 2026 02:25 UTCRecruitment status changed to recruiting · NCT07756736Psilocybin Recovery Intervention for Stopping Methamphetamine Use · observed Nov 10, 2026 02:27 UTCRegistry status changes · NCT06786325A Wellcome Leap for the Opioid Crisis: Can the 5HT2A Agonist Psilocybin Improve Brain, Behavioral, and Clinical Outcomes in Opioid Use Disorder (OUD)? · observed Nov 7, 2026 02:23 UTCRegistry status changes · NCT06660381Pilot Study of Psilocybin-assisted Treatment for Cannabis Use Disorder · observed Nov 6, 2026 02:24 UTCFirst observed recruiting · NCT07920081Psilocybin for Amblyopia - Targeting Critical Periods in Humans (PATCH) · observed Nov 6, 2026 02:24 UTCRegistry status changes · NCT05351541A Double-blind, Randomized Trial Examining the Preliminary Efficacy of Psilocybin Therapy for People With Chronic Low Back Pain · observed Nov 5, 2026 02:25 UTCRegistry status changes · NCT06001749Feasibility Phase 2 Study of Psilocybin-Assisted Therapy for Opioid-Refractory Pain in Patients With Advanced Cancer · observed Oct 28, 2026 02:24 UTCRecruitment status changed to recruiting · NCT07405606Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder: A Pilot Randomized Clinical Trial · observed Oct 27, 2026 02:22 UTCRecruitment status changed to recruiting · NCT07391332Psilocybin AsSisted pSychotherapy for the treatmENt of Gambling disordER: a Pilot Study · observed Oct 17, 2026 01:22 UTCRegistry status changes · NCT05554094Examining the Safety and Clinical Efficacy of Psilocybin Therapy for Veterans With PTSD: An Open-Label Proof-of-Concept Trial · observed Oct 17, 2026 01:22 UTCRegistry status changes · NCT05224336Behavioral and Neural Mechanisms Supporting Psilocybin-assisted Therapy for Phantom Limb Pain · observed Oct 12, 2026 07:04 UTC
Opt in to research-change email alerts. Journal and citation filters apply to publications; use keyword, sponsor/author and topic filters for registry changes.
Monthly literature view
80 records have publication dates within this month. Issue dates may be assigned ahead of online availability. Date-added activity and publication-date activity describe different events.
Modelling vortex interactions reveals distinct patterns of brain reconfiguration following psilocybin and escitalopram2026-11-19 · bioRxiv · PREPRINT (not peer reviewed)Psilocybin reproducibility2026-11-19 · Crossref · PublishedMescaline enhances emotional empathy via 5-HT receptor activation.2026-11-19 · PubMed · PublishedTargeting CGRP signaling reverses maladaptive neurogenic immunosuppression in head and neck squamous cell carcinoma models.2026-11-19 · PubMed · PublishedTaxonomic diversity and psilocybin detection in “superfamily” Strophariacea from China, with descriptions of two new species2026-11-18 · Crossref · PublishedNovel quantification method for psilocin in brain tissues using liquid chromatography-tandem mass spectrometry.2026-11-18 · Europe PMC · PublishedA Placebo Cannot Be Psychedelic: Why psychedelic trials need dose, not mimicry, as their control2026-11-18 · PsyArXiv · PREPRINT (not peer reviewed)Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's Disease2026-11-18 · ClinicalTrials.gov · CLINICAL TRIALToward Patient-Tailored Care for Treatment-Resistant Depression: A Pilot Patient-Preference Clinical Trial of Music and Mindfulness in Psilocybin-Assisted Psychotherapy2026-11-18 · ClinicalTrials.gov · CLINICAL TRIALPsilocybin induces delayed and dynamic changes in human sleep neurophysiology: Results from a randomized controlled trial of psilocybin assisted therapy in patients with comorbid major depressive and alcohol use disorder2026-11-17 · Europe PMC · PREPRINT (not peer reviewed)Psychedelic treatment for headache disorders.2026-11-17 · Europe PMC · PublishedMultidimensional Self-Transcendent Experiences in Psychedelic Use: Distinct Associations with Mindset, Affect, and Positive Effects2026-11-17 · PsyArXiv · PREPRINT (not peer reviewed)An Examination of Psilocybin Effects on Biomarkers of Longevity, Healthy Aging, and Purpose in Life2026-11-17 · ClinicalTrials.gov · CLINICAL TRIALEfficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive Symptoms2026-11-17 · ClinicalTrials.gov · CLINICAL TRIALA Pilot Mechanistic Study of Psilocybin-Assisted Therapy as a Treatment for Depression2026-11-17 · ClinicalTrials.gov · CLINICAL TRIALTracking single neurons across days reveals acute and persistent effects of psilocybin in the mouse brain2026-11-16 · bioRxiv · PREPRINT (not peer reviewed)The social conditioned place preference assay is sensitive to drug dose, training regimen, and social context2026-11-16 · bioRxiv · PREPRINT (not peer reviewed)Safety, Feasibility, and Tolerability of Psilocybin Treatment for Individuals With Functional Impairment Related to Mood, Anxiety, Trauma and/or Addiction Symptoms: An Open-label Proof-of-concept Study2026-11-16 · ClinicalTrials.gov · CLINICAL TRIALPrior trauma shapes the effects of psilocybin on stress sensitization in mice.2026-11-15 · PubMed · PublishedQuality of Life and the Case for Consent-Based Psilocybin Access - Questions on the Regulatory Framework and Cost2026-11-14 · PsyArXiv · PREPRINT (not peer reviewed)Psilocybin-Assisted Therapy for Existential Distress in Serious and Life-Limiting Illness: Emerging Trial Evidence, Barriers to Access, and the Case for Individualized Eligibility2026-11-14 · PsyArXiv · PREPRINT (not peer reviewed)Cost-effectiveness of psychedelic-assisted therapies for depression and post-traumatic stress disorder: A systematic review.2026-11-13 · Europe PMC · PublishedRoots to Thrive risk and readiness assessment: a practice-based intake and decision-support framework for psychedelic-assisted therapy.2026-11-13 · PubMed · PublishedCurrent perspectives in the pharmacological treatment of gambling disorder: psychedelics and beyond.2026-11-13 · Europe PMC · PublishedPsilocybin enhances conditioned place preference learning in planarians.2026-11-13 · Europe PMC · PublishedHow Does Psilocybin Affect Daily Life Experience and Behavior? Protocol For a Multimethod Ambulatory Assessment Study Within a Clinical Trial of Psilocybin for Depression2026-11-12 · medRxiv · PREPRINT (not peer reviewed)Connectedness as a candidate pathway linking psilocybin retreat experiences to sustained wellbeing: a prospective naturalistic study2026-11-12 · Europe PMC · PublishedThe Effects of Psilocybin on Social Connectedness2026-11-12 · ClinicalTrials.gov · CLINICAL TRIALPsilocybin With Intracranial Neural Sensing2026-11-12 · ClinicalTrials.gov · CLINICAL TRIALNeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy2026-11-12 · ClinicalTrials.gov · CLINICAL TRIALA Phase 2b/3, Multicentre, Randomised, Double-blind, Controlled Trial, With an Open Label Extension, to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder2026-11-12 · ClinicalTrials.gov · CLINICAL TRIALFrom Rapid Synaptic Events to Lasting Antidepressant States: Convergent and Divergent Mechanisms of Ketamine and Psychedelics.2026-11-11 · Europe PMC · PublishedExploring subacute effects of a DMT and harmine meditation retreat on the brain's control energy landscape2026-11-11 · bioRxiv · PREPRINT (not peer reviewed)The "dark magic mushroom" co-produces amatoxins and psilocybin.2026-11-11 · Europe PMC · PublishedPsychedelic-assisted therapies (Psilocybin and MDMA) for treatment-resistant psychiatric disorders2026-11-10 · Crossref · PublishedChanges in self-related cognitive processes and depressive symptom severity following a single, moderate dose of psilocybin in depressed patients2026-11-10 · Crossref · PublishedEffects of Psilocybin on Speech Fluency, Struggle, and Brain Activity in People Who Stutter2026-11-10 · ClinicalTrials.gov · CLINICAL TRIALPsilocybin for anorexia nervosa: efficacy, safety, and durability of clinical effects: a systematic review of clinical trials2026-11-09 · Crossref · PublishedPsilocybin Recovery Intervention for Stopping Methamphetamine Use2026-11-09 · ClinicalTrials.gov · CLINICAL TRIALRapid antidepressant effects of psilocybin without increased SV2A binding: baseline binding predicts response2026-11-08 · medRxiv · PREPRINT (not peer reviewed)Psilocybin-assisted therapy for alcohol use disorder: A systematic review of randomized controlled trials2026-11-06 · Crossref · PublishedPharmacist Guide to Psilocybin and Psychedelic-Assisted Psychotherapy.2026-11-06 · Europe PMC · PublishedInvestigating the Role of Serotonin in the Mechanism of Action of Psilocybin in Patients With Major Depressive Disorder2026-11-06 · ClinicalTrials.gov · CLINICAL TRIALRole of Experience, Conscious Awareness, and Plasticity in Psilocybin's Behavioral Effects - Follow-Up Study (The RECAP 2 Study)2026-11-06 · ClinicalTrials.gov · CLINICAL TRIALA Wellcome Leap for the Opioid Crisis: Can the 5HT2A Agonist Psilocybin Improve Brain, Behavioral, and Clinical Outcomes in Opioid Use Disorder (OUD)?2026-11-06 · ClinicalTrials.gov · CLINICAL TRIALPsilocybin for Amblyopia - Targeting Critical Periods in Humans (PATCH)2026-11-05 · ClinicalTrials.gov · CLINICAL TRIALA Topology of the Psilocybin Experience Reveals Cognitive-Emotional Drivers, Unitive State Divergence, and Psychometric Feature Cancellation2026-11-05 · PsyArXiv · PREPRINT (not peer reviewed)Which Psychedelic Therapy Should Rural Health Systems Pursue First: Psilocybin or Ibogaine?2026-11-05 · Crossref · PublishedPsilocybin modulates nucleus accumbens activity via astrocytic transcriptional regulation.2026-11-05 · Europe PMC · PublishedA Phase 1b Study to Evaluate the Safety and Tolerability of MLS101 Treatment for Premenstrual Dysphoric Disorder (PMDD)2026-11-05 · ClinicalTrials.gov · CLINICAL TRIAL
Recently indexed records
These entries are ordered by when they entered this index, not when the underlying study was conducted or published. A newly indexed old paper is not a new finding.
Modelling vortex interactions reveals distinct patterns of brain reconfiguration following psilocybin and escitalopramIndexed 2026-11-20 02:22:21 · publication date 2026-11-19 · PREPRINT (not peer reviewed)Psilocybin induces delayed and dynamic changes in human sleep neurophysiology: Results from a randomized controlled trial of psilocybin assisted therapy in patients with comorbid major depressive and alcohol use disorderIndexed 2026-11-20 02:20:18 · publication date 2026-11-17 · PREPRINT (not peer reviewed)Psilocybin reproducibilityIndexed 2026-11-20 02:20:15 · publication date 2026-11-19 · PublishedCost-effectiveness of psychedelic-assisted therapies for depression and post-traumatic stress disorder: A systematic review.Indexed 2026-11-20 02:20:08 · publication date 2026-11-13 · PublishedMescaline enhances emotional empathy via 5-HT receptor activation.Indexed 2026-11-20 02:20:07 · publication date 2026-11-19 · PublishedTargeting CGRP signaling reverses maladaptive neurogenic immunosuppression in head and neck squamous cell carcinoma models.Indexed 2026-11-20 02:20:06 · publication date 2026-11-19 · PublishedTaxonomic diversity and psilocybin detection in “superfamily” Strophariacea from China, with descriptions of two new speciesIndexed 2026-11-19 02:20:12 · publication date 2026-11-18 · PublishedRoots to Thrive risk and readiness assessment: a practice-based intake and decision-support framework for psychedelic-assisted therapy.Indexed 2026-11-19 02:20:06 · publication date 2026-11-13 · PublishedPsychedelic treatment for headache disorders.Indexed 2026-11-19 02:20:06 · publication date 2026-11-17 · PublishedNovel quantification method for psilocin in brain tissues using liquid chromatography-tandem mass spectrometry.Indexed 2026-11-19 02:20:06 · publication date 2026-11-18 · PublishedMultidimensional Self-Transcendent Experiences in Psychedelic Use: Distinct Associations with Mindset, Affect, and Positive EffectsIndexed 2026-11-18 02:23:24 · publication date 2026-11-17 · PREPRINT (not peer reviewed)Tracking single neurons across days reveals acute and persistent effects of psilocybin in the mouse brainIndexed 2026-11-17 02:22:19 · publication date 2026-11-16 · PREPRINT (not peer reviewed)The social conditioned place preference assay is sensitive to drug dose, training regimen, and social contextIndexed 2026-11-17 02:22:19 · publication date 2026-11-16 · PREPRINT (not peer reviewed)Single-dose psilocybin superior to placebo for MDD in community settingIndexed 2026-11-15 02:20:13 · publication date 2026-12-01 · PublishedPilot study supports broader research on psilocybin for anorexia nervosaIndexed 2026-11-15 02:20:13 · publication date 2026-12-01 · Published